Did you all see this?Preliminary results from an ongoing Phase 1 clinical trial indicate that carfilzomib, a new proteasome inhibitor, has significant therapeutic results in patients with relapsed myeloma. The Multiple Myeloma Research Consortium (MMRC) reported the results at the Joint ECCO 15-34th ESMO Multidisciplinary Congress, which was held in Berlin from September 20 to
I want to take a time-out today and stop and remember the patients that aren’t doing so well – that aren’t responding to Revlimid, or Velcade, or who suffer a re-lapse after only a few short moths or years after undergoing a painful and risky stem cell transplant.Patients like Rebbecca from a suburb of Tampa,
I want to preface my comments by admitting I don't know enough about the program to give more than my initial reactions to the program. I also want to take this opportunity to thank Nick van Dyk for his willingness to take the time to give us an outline of the therapy plan - his
Nick has generously agreed to help educate us about Total Therapy. This is a new concept for me, but I know some of you are familiar with this treatment philosophy. Nick wrote this yesterday:As for getting primed about Total Therapy, I would refer you via google to a powerpoint presentation called "The Myth of Incurability."
I recieved the following e-mail from a cyber friend of mine, Nick Van Dyk, who is a 41 year old myeloma patient that has choosen a very aggressive therapy approach in an attempt to actually cure his multiple myeloma. Nick works with doctors in Little Rock, Arkansas. If you follow my blog you may have
Most oncologists know not to administer melphalan chemotherapy for myeloma patients that need stem cells harvested for possible transplant. But far fewer are aware of the negative effects radiation therapy can have on a patient's ability to mobilize stem cells into the blood for harvest. I had a very difficult time producing enough stem cells
On my other blog, www.HelpWithCancer.Org, Pattie and I just commented about the NFL and how the league is helping to raise breast cancer awareness by having players and coaches wear pink shoe laces, hats and accessories before, during and after the games. Anyway, short and sweet, here is what we wrote:The NFL Looks Good In
According to Cure Magazine, the successful myeloma chemotherapy drug, Revlimid, is also used to help patients with myelodysplastic syndromes. MDS is a catch-all diagnosis for a number of different blood disorders that usually require regular transfusion therapy. Use of Revlimid among certain types of MDS improved hemoglobin levels and close to 70% of these patients
Connecticut has a very large and active multiple myeloma support group. Affiliated with the IMF, the group has just launched a new Website. It is just getting started, so I wasn't too impressed. However, their technical assistance link for myeloma patients and caregivers is excellent! Very comprehensive. Click here to travel to their resource site.
The three novel chemotherapy agents (Revlimid, Velcade, Thalomid) now commonly used to treat multiple myeloma have been so successful it has created an unforeseen problem. According to Dr. Shaji Kumar with Mayo Clinic, improved outcomes for the majority of myeloma patients using these drugs makes it more difficult to bring other, new drugs to market.